Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Biliary Tract Diseases

Free Subscription Articles published in PLoS One Retrieve available abstracts of 91 articles: HTML format

Single Articles

January 2020
1. TSUKUDA S, Ikeura T, Ito T, Nakamaru K, et al
   Clinical implications of elevated serum interleukin-6 in IgG4-related disease.
   PLoS One. 2020;15:e0227479.
   PubMed     Abstract available
   
   
   
2. AKARA-AMORNTHUM P, Lomphithak T, Choksi S, Tohtong R, et al
   Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-alpha and chemotherapeutic gemcitabine-induced necroptosis.
   PLoS One. 2020;15:e0227454.
   PubMed     Abstract available
   
   
   
3. ARTHUIS C, Diguisto C, Lorphelin H, Dochez V, et al
   Perinatal outcomes of intrahepatic cholestasis during pregnancy: An 8-year case-control study.
   PLoS One. 2020;15:e0228213.
   PubMed     Abstract available
   
   
   
4. HAHN F, Muller L, Mahringer-Kunz A, Schotten S, et al
   Risk prediction in intrahepatic cholangiocarcinoma: Direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC Cancer staging system.
   PLoS One. 2020;15:e0228501.
   PubMed     Abstract available
   
   
   
5. KE Q, Lin N, Deng M, Wang L, et al
   The effect of adjuvant therapy for patients with intrahepatic cholangiocarcinoma after surgical resection: A systematic review and meta-analysis.
   PLoS One. 2020;15:e0229292.
   PubMed     Abstract available
   
   
   
6. YOO YJ, Kang CM, Choi M, Rho SY, et al
   Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer.
   PLoS One. 2020;15:e0229597.
   PubMed     Abstract available
   
   
   
7. LIN SY, Lin CL, Hsu WH, Wang IK, et al
   Risk of biliary tract disease in living liver donors: A population-based cohort study.
   PLoS One. 2020;15:e0230840.
   PubMed     Abstract available
   
   
   January 2019
8. DI MATTEO S, Nevi L, Costantini D, Overi D, et al
   The FXR agonist obeticholic acid inhibits the cancerogenic potential of human cholangiocarcinoma.
   PLoS One. 2019;14:e0210077.
   PubMed     Abstract available
   
   
   
9. KOBAYASHI M, Ryozawa S, Iwano H, Araki R, et al
   The usefulness of wire-guided endoscopic snare papillectomy for tumors of the major duodenal papilla.
   PLoS One. 2019;14:e0211019.
   PubMed     Abstract available
   
   
   
10. KEIL R, Drabek J, Lochmannova J, Stovicek J, et al
    ERCP in infants, children, and adolescents-Different roles of the methods in different age groups.
    PLoS One. 2019;14:e0210805.
    PubMed     Abstract available
    
    
    
11. ABURAWI EH, Al Hamad S, Yasin J, Almekhaini LA, et al
    Dyslipidemia, subclinical inflammation, hepatic cholestasis and endothelial dysfunction in schoolchildren with excess fat: A study from the United Arab Emirates.
    PLoS One. 2019;14:e0210316.
    PubMed     Abstract available
    
    
    
12. LOOSEN SH, Lurje G, Wiltberger G, Vucur M, et al
    Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma.
    PLoS One. 2019;14:e0210944.
    PubMed     Abstract available
    
    
    
13. MISZCZUK GS, Banales JM, Zucchetti AE, Pisani GB, et al
    Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasis.
    PLoS One. 2019;14:e0212215.
    PubMed     Abstract available
    
    
    
14. PARK DW, Lee YJ, Chang W, Park JH, et al
    Diagnostic performance of a point shear wave elastography (pSWE) for hepatic fibrosis in patients with autoimmune liver disease.
    PLoS One. 2019;14:e0212771.
    PubMed     Abstract available
    
    
    
15. MOSHER V, Swain M, Pang J, Kaplan G, et al
    Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.
    PLoS One. 2019;14:e0211906.
    PubMed     Abstract available
    
    
    
16. KIM HS, Cho SK, Kim CS, Park JS, et al
    Big data and analysis of risk factors for gallbladder disease in the young generation of Korea.
    PLoS One. 2019;14:e0211480.
    PubMed     Abstract available
    
    
    
17. AICHER KM, Cullen JM, Seiler GS, Lunn KF, et al
    Investigation of adrenal and thyroid gland dysfunction in dogs with ultrasonographic diagnosis of gallbladder mucocele formation.
    PLoS One. 2019;14:e0212638.
    PubMed     Abstract available
    
    
    
18. PROMRAKSA B, Phetcharaburanin J, Namwat N, Techasen A, et al
    Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines.
    PLoS One. 2019;14:e0216721.
    PubMed     Abstract available
    
    
    
19. PENG CH, Lee HC, Jiang CB, Hsu CK, et al
    Serum vitamin D level is inversely associated with liver fibrosis in post Kasai's portoenterostomy biliary atresia patients living with native liver.
    PLoS One. 2019;14:e0218896.
    PubMed     Abstract available
    
    
    
20. PANG S, Ding T, Qiao S, Meng F, et al
    A novel YOLOv3-arch model for identifying cholelithiasis and classifying gallstones on CT images.
    PLoS One. 2019;14:e0217647.
    PubMed     Abstract available
    
    
    
21. MORIS D, Kostakis ID, Machairas N, Prodromidou A, et al
    Comparison between liver transplantation and resection for hilar cholangiocarcinoma: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0220527.
    PubMed     Abstract available
    
    
    
22. PANG S, Wang S, Rodriguez-Paton A, Li P, et al
    An artificial intelligent diagnostic system on mobile Android terminals for cholelithiasis by lightweight convolutional neural network.
    PLoS One. 2019;14:e0221720.
    PubMed     Abstract available
    
    
    
23. MIYAMOTO T, Ebihara T, Kozaki K
    The association between eating difficulties and biliary sludge in the gallbladder in older adults with advanced dementia, at end of life.
    PLoS One. 2019;14:e0219538.
    PubMed     Abstract available
    
    
    
24. DUANGKUMPHA K, Stoll T, Phetcharaburanin J, Yongvanit P, et al
    Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis.
    PLoS One. 2019;14:e0221024.
    PubMed     Abstract available
    
    
    January 2018
25. ZENOUZI R, von der Gablentz J, Heldmann M, Gottlich M, et al
    Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure.
    PLoS One. 2018;13:e0190005.
    PubMed     Abstract available
    
    
    
26. IIDA T, Kaneto H, Wagatsuma K, Sasaki H, et al
    Efficacy and safety of endoscopic procedures for common bile duct stones in patients aged 85 years or older: A retrospective study.
    PLoS One. 2018;13:e0190665.
    PubMed     Abstract available
    
    
    
27. PERALDO-NEIA C, Cavalloni G, Fenocchio E, Cagnazzo C, et al
    Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.
    PLoS One. 2018;13:e0191593.
    PubMed     Abstract available
    
    
    
28. GOOKIN JL, Mathews KG, Cullen J, Seiler G, et al
    Qualitative metabolomics profiling of serum and bile from dogs with gallbladder mucocele formation.
    PLoS One. 2018;13:e0191076.
    PubMed     Abstract available
    
    
    
29. LEE HS, Chung MJ, Park JY, Bang S, et al
    Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis.
    PLoS One. 2018;13:e0190835.
    PubMed     Abstract available
    
    
    
30. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
    Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    PLoS One. 2018;13:e0193960.
    PubMed     Abstract available
    
    
    
31. ANDRES A, Montano-Loza A, Greiner R, Uhlich M, et al
    A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193523.
    PubMed     Abstract available
    
    
    
32. SHAHEEN AA, Kaplan GG, Almishri W, Vallerand I, et al
    The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
    PLoS One. 2018;13:e0194839.
    PubMed     Abstract available
    
    
    
33. BIAN S, Chen H, Wang L, Fei Y, et al
    Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
    PLoS One. 2018;13:e0194397.
    PubMed     Abstract available
    
    
    
34. LIAO CY, Chung CH, Chu P, Wei KY, et al
    Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    PLoS One. 2018;13:e0194418.
    PubMed     Abstract available
    
    
    
35. KELLER S, Aigner A, Zenouzi R, Kim AC, et al
    Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193929.
    PubMed     Abstract available
    
    
    
36. KANG J, Lee SH, Son JH, Lee JW, et al
    Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
    PLoS One. 2018;13:e0195118.
    PubMed     Abstract available
    
    
    
37. WIELDERS CLC, van Nierop P, Vormer TL, Foijer F, et al
    RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABAA receptors involved in volume regulation.
    PLoS One. 2018;13:e0196979.
    PubMed     Abstract available
    
    
    
38. LIU T, Wang W, Ji Y, Wang Y, et al
    Association between different combination of measures for obesity and new-onset gallstone disease.
    PLoS One. 2018;13:e0196457.
    PubMed     Abstract available
    
    
    
39. FRYBOVA B, Drabek J, Lochmannova J, Douda L, et al
    Cholelithiasis and choledocholithiasis in children; risk factors for development.
    PLoS One. 2018;13:e0196475.
    PubMed     Abstract available
    
    
    
40. RATTAY S, Graf D, Kislat A, Homey B, et al
    Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice.
    PLoS One. 2018;13:e0199863.
    PubMed     Abstract available
    
    
    
41. SILAKIT R, Kitirat Y, Thongchot S, Loilome W, et al
    Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.
    PLoS One. 2018;13:e0199827.
    PubMed     Abstract available
    
    
    
42. ABE K, Takahashi A, Fujita M, Imaizumi H, et al
    Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    PLoS One. 2018;13:e0198757.
    PubMed     Abstract available
    
    
    
43. IRANMANESH P, Tobler O, De Sousa S, Andres A, et al
    Feasibility, benefit and risk of systematic intraoperative cholangiogram in patients undergoing emergency cholecystectomy.
    PLoS One. 2018;13:e0199147.
    PubMed     Abstract available
    
    
    
44. SAMUEL S, Mukherjee S, Ammannagari N, Pokuri VK, et al
    Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study.
    PLoS One. 2018;13:e0198809.
    PubMed     Abstract available
    
    
    
45. NA SK, Choi GH, Lee HC, Shin YM, et al
    The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    PLoS One. 2018;13:e0198138.
    PubMed     Abstract available
    
    
    
46. KRUK B, Liebe R, Milkiewicz M, Wunsch E, et al
    PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
    PLoS One. 2018;13:e0202942.
    PubMed     Abstract available
    
    
    
47. PEISELER M, Reiners D, Pinnschmidt HO, Sebode M, et al
    Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
    PLoS One. 2018;13:e0202686.
    PubMed     Abstract available
    
    
    
48. GABBIA D, Pozzo L, Zigiotto G, Roverso M, et al
    Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.
    PLoS One. 2018;13:e0204336.
    PubMed     Abstract available
    
    
    
49. DE BARI B, Breuneval T, Zeverino M, Godin S, et al
    Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
    PLoS One. 2018;13:e0204013.
    PubMed     Abstract available
    
    
    
50. LIMPAWATTANA P, Theerakulpisut D, Wirasorn K, Sookprasert A, et al
    The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients.
    PLoS One. 2018;13:e0204985.
    PubMed     Abstract available
    
    
    
51. SILVA VIEIRA M, Arthurs CJ, Hussain T, Razavi R, et al
    Patient-specific modeling of right coronary circulation vulnerability post-liver transplant in Alagille's syndrome.
    PLoS One. 2018;13:e0205829.
    PubMed     Abstract available
    
    
    
52. HANDGRAAF HJM, Sibinga Mulder BG, Shahbazi Feshtali S, Boogerd LSF, et al
    Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer.
    PLoS One. 2018;13:e0205960.
    PubMed     Abstract available
    
    
    
53. LAMARCA A, Galdy S, Barriuso J, Moghadam S, et al
    The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
    PLoS One. 2018;13:e0206007.
    PubMed     Abstract available
    
    
    
54. NAKAMOTO S, Kumamoto Y, Igarashi K, Fujiyama Y, et al
    Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.
    PLoS One. 2018;13:e0205864.
    PubMed     Abstract available
    
    
    
55. KIM EJ, Chung DH, Kim YJ, Kim YS, et al
    Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    PLoS One. 2018;13:e0206694.
    PubMed     Abstract available
    
    
    
56. RAU M, Schmitt J, Berg T, Kremer AE, et al
    Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients.
    PLoS One. 2018;13:e0208225.
    PubMed     Abstract available
    
    
    
57. KUMAGAI J, Taida T, Ogasawara S, Nakagawa T, et al
    Clinical characteristics and outcomes of primary sclerosing cholangitis and ulcerative colitis in Japanese patients.
    PLoS One. 2018;13:e0209352.
    PubMed     Abstract available
    
    
    January 2017
58. ZEC S, Popovic D, Matovic V, Nikolic V, et al
    Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire.
    PLoS One. 2017;12:e0175697.
    PubMed     Abstract available
    
    
    
59. HUSZAR O, Kokas B, Matrai P, Hegyi P, et al
    Meta-Analysis of the Long Term Success Rate of Different Interventions in Benign Biliary Strictures.
    PLoS One. 2017;12:e0169618.
    PubMed     Abstract available
    
    
    
60. REUKEN PA, Torres D, Baier M, Loffler B, et al
    Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis.
    PLoS One. 2017;12:e0169900.
    PubMed     Abstract available
    
    
    
61. UDOMSINPRASERT W, Kitkumthorn N, Mutirangura A, Chongsrisawat V, et al
    Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia.
    PLoS One. 2017;12:e0169306.
    PubMed     Abstract available
    
    
    
62. NELSON SM, Gao YT, Nogueira LM, Shen MC, et al
    Diet and biliary tract cancer risk in Shanghai, China.
    PLoS One. 2017;12:e0173935.
    PubMed     Abstract available
    
    
    
63. CHEN JH, Borges M
    Histopathology and enhanced detection of tumor invasion of peritoneal membranes.
    PLoS One. 2017;12:e0173833.
    PubMed     Abstract available
    
    
    
64. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Abstract available
    
    
    
65. DE LOMBAERDE S, Neyt S, Kersemans K, Verhoeven J, et al
    Synthesis, in vitro and in vivo evaluation of 3beta-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
    PLoS One. 2017;12:e0173529.
    PubMed     Abstract available
    
    
    
66. CHO S, Lee TS, Song IH, Kim AR, et al
    Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.
    PLoS One. 2017;12:e0170078.
    PubMed     Abstract available
    
    
    
67. ESTIU MC, Frailuna MA, Otero C, Dericco M, et al
    Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.
    PLoS One. 2017;12:e0176504.
    PubMed     Abstract available
    
    
    
68. KEMPINSKA-PODHORODECKA A, Milkiewicz M, Jablonski D, Milkiewicz P, et al
    ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis.
    PLoS One. 2017;12:e0176264.
    PubMed     Abstract available
    
    
    
69. YAGAI T, Matsui S, Harada K, Inagaki FF, et al
    Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree.
    PLoS One. 2017;12:e0175355.
    PubMed     Abstract available
    
    
    
70. QU X, Sheng J, Shen L, Su J, et al
    Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
    PLoS One. 2017;12:e0173712.
    PubMed     Abstract available
    
    
    
71. RAO ZZ, Zhang XW, Ding YL, Yang MY, et al
    miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3.
    PLoS One. 2017;12:e0178702.
    PubMed     Abstract available
    
    
    
72. SHNEIDER BL, Moore J, Kerkar N, Magee JC, et al
    Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?
    PLoS One. 2017;12:e0176275.
    PubMed     Abstract available
    
    
    
73. IINO C, Shimoyama T, Igarashi T, Aihara T, et al
    Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.
    PLoS One. 2017;12:e0178777.
    PubMed     Abstract available
    
    
    
74. GRANATA V, Fusco R, Catalano O, Avallone A, et al
    Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    PLoS One. 2017;12:e0179951.
    PubMed     Abstract available
    
    
    
75. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Abstract available
    
    
    
76. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    PubMed     Abstract available
    
    
    
77. KATO S, Chinen K, Shinoura S, Kikuchi K, et al
    Predictors for bile duct stone recurrence after endoscopic extraction for naive major duodenal papilla: A cohort study.
    PLoS One. 2017;12:e0180536.
    PubMed     Abstract available
    
    
    
78. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Abstract available
    
    
    
79. PEREIRA P, Aho V, Arola J, Boyd S, et al
    Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
    PLoS One. 2017;12:e0182924.
    PubMed     Abstract available
    
    
    
80. JEE J, Mourya R, Shivakumar P, Fei L, et al
    Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia.
    PLoS One. 2017;12:e0182089.
    PubMed     Abstract available
    
    
    
81. ADEYEMI O, Alvarez-Laviada A, Schultz F, Ibrahim E, et al
    Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis.
    PLoS One. 2017;12:e0183167.
    PubMed     Abstract available
    
    
    
82. WANG X, Wen X, Zhou J, Qi Y, et al
    MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients.
    PLoS One. 2017;12:e0184292.
    PubMed     Abstract available
    
    
    
83. FAGAGNINI S, Heinrich H, Rossel JB, Biedermann L, et al
    Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.
    PLoS One. 2017;12:e0185193.
    PubMed     Abstract available
    
    
    
84. YE Y, Li Z, Feng Q, Chen Z, et al
    Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3.
    PLoS One. 2017;12:e0180896.
    PubMed     Abstract available
    
    
    
85. PETRICK JL, Yang B, Altekruse SF, Van Dyke AL, et al
    Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
    PLoS One. 2017;12:e0186643.
    PubMed     Abstract available
    
    
    
86. LEE S, Kweon OK, Kim WH
    Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs.
    PLoS One. 2017;12:e0187315.
    PubMed     Abstract available
    
    
    
87. IGARASHI K, Yamashita K, Katoh H, Kojima K, et al
    Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
    PLoS One. 2017;12:e0188178.
    PubMed     Abstract available
    
    
    
88. PINHEIRO D, Leiros L, Dau JBT, Stumbo AC, et al
    Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice.
    PLoS One. 2017;12:e0187970.
    PubMed     Abstract available
    
    
    January 2016
89. HUANG SG, Guo WL, Wang J, Sheng M, et al
    Factors Interfering with Delineation on MRCP of Pancreaticobiliary Maljunction in Paediatric Patients.
    PLoS One. 2016;11:e0154178.
    PubMed     Abstract available
    
    
    
90. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Abstract available
    
    
    
91. MANTEL HT, Westerkamp AC, Adam R, Bennet WF, et al
    Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.
    PLoS One. 2016;11:e0156127.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: